Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Luke Byerly"'
Autor:
Mark Wunderlich, Nicole Manning, Christina Sexton, Eric O’Brien, Luke Byerly, Cody Stillwell, John P. Perentesis, James C. Mulloy, Benjamin Mizukawa
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Immune therapies such as blinatumomab, CD19-directed bispecific CD3 T-cell Engager (BiTE), have resulted in significant improvements in outcomes for relapsed B-cell acute lymphoblastic leukemia (B-ALL). However, up to half of blinatumomab treated pat
Externí odkaz:
https://doaj.org/article/5dda746341a54c8bacc19c67b5f3d649
Autor:
Mark Wunderlich, Nicole Manning, Christina Sexton, Anthony Sabulski, Luke Byerly, Eric O'Brien, John P Perentesis, Benjamin Mizukawa, James C Mulloy
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0225532 (2019)
We have previously characterized an acute myeloid leukemia (AML) chemotherapy model for SCID-based immune deficient mice (NSG and NSGS), consisting of 5 days of cytarabine (AraC) and 3 days of anthracycline (doxorubicin), to simulate the standard 7+3
Externí odkaz:
https://doaj.org/article/cd47170d50ec4a2e8bcc41f4eec1940c
Publikováno v:
The Journal of bone and joint surgery. American volume. 104(13)
The transphyseal distal humeral fracture has been well described as a concerning fracture pattern for non-accidental trauma (NAT) in young pediatric patients. Because of the infrequent presentation of this fracture, the association historically has b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93849c8b31504e88666b3631766e4d2a
https://pubmed.ncbi.nlm.nih.gov/35793799
https://pubmed.ncbi.nlm.nih.gov/35793799
Autor:
Mark Wunderlich, Jing Chen, Christina Sexton, Nicole Manning, Luke Byerly, Eric O’Brien, John P. Perentesis, James C. Mulloy, Benjamin Mizukawa
As patient-derived xenograft (PDX) models of acute myeloid leukemia (AML) become increasingly common tools for preclinical evaluation of targeted therapies it becomes important to consider the fidelity with which this system recapitulates the disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05b09a4f36a4a29f9964a795e6b79e1d
https://doi.org/10.1101/2022.01.31.478534
https://doi.org/10.1101/2022.01.31.478534
Autor:
Cody Stillwell, Christina Sexton, John P. Perentesis, Mark Wunderlich, James C. Mulloy, Nicole Manning, Luke Byerly, Eric O'Brien, Benjamin Mizukawa
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
Immune therapies such as blinatumomab, CD19-directed bispecific CD3 T-cell Engager (BiTE), have resulted in significant improvements in outcomes for relapsed B-cell acute lymphoblastic leukemia (B-ALL). However, up to half of blinatumomab treated pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6da767e01ab6457d2df2156aa38a6c18
https://doi.org/10.3389/fonc.2021.642466
https://doi.org/10.3389/fonc.2021.642466
Autor:
Xin Duan, Mei Xin, Yoshinobu Odaka, Richard A. Lang, Qing Richard Lu, Jiukuan Hao, Marcus Fruttiger, Ning Liu, Megan Donaldson, Masahide Sakabe, Jieqing Fan, Yi Zheng, Aishlin Hassan, Luke Byerly, Paige Stump
Publikováno v:
Proceedings of the National Academy of Sciences. 114:10918-10923
Angiogenesis and vascular remodeling are essential for the establishment of vascular networks during organogenesis. Here we show that the Hippo signaling pathway effectors YAP and TAZ are required, in a gene dosage-dependent manner, for the prolifera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54254f0f292cf26c528ebfb536e5352a
https://doi.org/10.1073/pnas.1704030114
https://doi.org/10.1073/pnas.1704030114
Autor:
Nicole Manning, James C. Mulloy, Benjamin Mizukawa, Christina Sexton, John P. Perentesis, Mark Wunderlich, Luke Byerly, Anthony Sabulski, Eric O'Brien
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0225532 (2019)
PLoS ONE
PLoS ONE
We have previously characterized an acute myeloid leukemia (AML) chemotherapy model for SCID-based immune deficient mice (NSG and NSGS), consisting of 5 days of cytarabine (AraC) and 3 days of anthracycline (doxorubicin), to simulate the standard 7+3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0f31d7a86c6b7763c228dd252e21703
https://doaj.org/article/cd47170d50ec4a2e8bcc41f4eec1940c
https://doaj.org/article/cd47170d50ec4a2e8bcc41f4eec1940c
Publikováno v:
Journal of Bacteriology. 198:2228-2235
Neisseria gonorrhoeae causes the human-specific disease gonorrhea and is transmitted from person to person primarily via sexual contact. During transmission, N. gonorrhoeae is often exposed to seminal fluid and must adapt to this change in environmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0fd10ac9771f0ba809fa4e7f32159e3
https://doi.org/10.1128/jb.00165-16
https://doi.org/10.1128/jb.00165-16
Autor:
Mark Wunderlich, Benjamin Mizukawa, James C. Mulloy, Jing Chen, Nicole Manning, Eric O'Brien, Luke Byerly, Christina Sexton, John P. Perentesis
Publikováno v:
Blood. 134:3766-3766
Therapies for pediatric acute myeloid leukemia (AML) remain unsatisfactory and generally do not incorporate molecularly-targeted agents aside from FLT3 inhibitors outside of the relapse setting. Patient-derived xenograft (PDX) models of AML are incre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f740a428b191a50efae2646b161ab9d3
https://doi.org/10.1182/blood-2019-129225
https://doi.org/10.1182/blood-2019-129225
Autor:
David E. Soper, Luke Byerly, Margaret R. Ketterer, J. Dennis Fortenberry, Peter A. Rice, Michael A. Apicella, Steven Kiel, Sunita Gulati
Publikováno v:
The Journal of infectious diseases. 214(11)
Previous studies have demonstrated that Neisseria gonorrhoeae sialylates the terminal N-acetyllactosamine present on its lipooligosaccharide (LOS) by acquiring CMP-N-acetyl-5-neuraminic acid upon entering human cells during infection. This renders th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::357523f2c99c657371fa78d009f6c9e8
https://pubmed.ncbi.nlm.nih.gov/27530264
https://pubmed.ncbi.nlm.nih.gov/27530264